Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

ProQR Therapeutics FY EPS $(0.38) Up From $(0.97) YoY

Author: Benzinga Newsdesk | March 13, 2024 07:09am
ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.38) per share. This is a 61.09 percent increase over losses of $(0.97) per share from the same period last year.

Posted In: PRQR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist